← Cancer Research Communications
Papers in Cancer Research Communications
Page 14 · newest first
- Optimizing Early-stage Clinical Pharmacology Evaluation to Accelerate Clinical Development of Giredestrant in Advanced Breast CancerCancer Research Communications · 2023
- Polygenic Risk Score Modifies Prostate Cancer Risk of Pathogenic Variants in Men of African AncestryCancer Research Communications · 2023
- Activating Transcription Factor 5 Promotes Neuroblastoma Metastasis by Inducing Anoikis ResistanceCancer Research Communications · 2023
- Physical Activity During Adolescence and Early-adulthood and Ovarian Cancer Among Women with a BRCA1 or BRCA2 MutationCancer Research Communications · 2023
- Integrin-αvβ3 is a Therapeutically Targetable Fundamental Factor in Medulloblastoma Tumorigenicity and RadioresistanceCancer Research Communications · 2023
- Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of SarcomasCancer Research Communications · 2023
- Multifactorial Remodeling of the Cancer Immunopeptidome by IFNγCancer Research Communications · 2023
- CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma ActivityCancer Research Communications · 2023
- Longitudinal Natural History Study of Children and Adults with Rare Solid Tumors: Initial Results for First 200 ParticipantsCancer Research Communications · 2023
- Statin-induced Mitochondrial Priming Sensitizes Multiple Myeloma Cells to BCL2 and MCL-1 InhibitorsCancer Research Communications · 2023
- Phase Ib Trial of Phenformin in Patients with V600-mutated Melanoma Receiving Dabrafenib and TrametinibCancer Research Communications · 2023
- Risk Prediction of Metachronous Colorectal Cancer from Molecular Features of Adenomas: A Nested Case–Control StudyCancer Research Communications · 2023
- Mathematical Modeling Identifies Optimum Palbociclib-fulvestrant Dose Administration Schedules for the Treatment of Patients with Estrogen Receptor–positive Breast CancerCancer Research Communications · 2023
- Pathogenic Germline Variants in BRCA1/2 and p53 Identified by Real-world Comprehensive Cancer Genome Profiling Tests in Asian PatientsCancer Research Communications · 2023
- Ultra-Deep Sequencing Reveals the Mutational Landscape of Classical Hodgkin LymphomaCancer Research Communications · 2023
- Cancer-prone Phenotypes and Gene Expression Heterogeneity at Single-cell Resolution in Cigarette-smoking LungsCancer Research Communications · 2023
- Population-specific Mutation Patterns in Breast Tumors from African American, European American, and Kenyan PatientsCancer Research Communications · 2023
- SIX4 Controls Anti-PD-1 Efficacy by Regulating STING ExpressionCancer Research Communications · 2023
- Enitociclib, a Selective CDK9 Inhibitor, Induces Complete Regression of MYC+ Lymphoma by Downregulation of RNA Polymerase II Mediated TranscriptionCancer Research Communications · 2023
- Activation of KrasG12D in Subset of Alveolar Type II Cells Enhances Cellular Plasticity in Lung AdenocarcinomaCancer Research Communications · 2023
- Concordance and Clinical Significance of Genomic Alterations in Progressive Tumor Tissue and Matched Circulating Tumor DNA in Aggressive-variant Prostate CancerCancer Research Communications · 2023
- Targeted Degradation of XIAP is Sufficient and Specific to Induce Apoptosis in MYCN-overexpressing High-risk NeuroblastomaCancer Research Communications · 2023
- Sigma1 Regulates Lipid Droplet–Mediated Redox Homeostasis Required for Prostate Cancer ProliferationThe Medicine Forum · 2023
- Cancer Relevance of Circulating Antibodies Against LINE-1 Antigens in HumansCancer Research Communications · 2023
- PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and ChemotherapiesCancer Research Communications · 2023
- Antitumor Effects of PRMT5 Inhibition in SarcomasCancer Research Communications · 2023
- Exogenous Sequences in Tumors and Immune Cells (Exotic): A Tool for Estimating the Microbe Abundances in Tumor RNA-seq DataCancer Research Communications · 2023
- Statistical Assessment of Drug Synergy from In Vivo Combination Studies Using Mouse Tumor ModelsCancer Research Communications · 2023
- High In Vitro and In Vivo Activity of BI-847325, a Dual MEK/Aurora Kinase Inhibitor, in Human Solid and Hematologic Cancer ModelsCancer Research Communications · 2023
- Ewing Sarcoma Single-cell Transcriptome Analysis Reveals Functionally Impaired Antigen-presenting CellsCancer Research Communications · 2023
- Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate CancersCancer Research Communications · 2023
- Immune Cell Abundance and T-cell Receptor Landscapes Suggest New Patient Stratification Strategies in Head and Neck Squamous Cell CarcinomaCancer Research Communications · 2023
- PSGL-1 Blockade Induces Classical Activation of Human Tumor-associated MacrophagesCancer Research Communications · 2023
- Immune-related Adverse Events after Immune Checkpoint Blockade–based Therapy Are Associated with Improved Survival in Advanced SarcomasCancer Research Communications · 2023
- Impact of Eliminating Cost-Sharing by Medicare Beneficiaries for Follow-Up Colonoscopy After a Positive Stool-based Colorectal Cancer Screening TestCancer Research Communications · 2023
- Peritumoral Immune-suppressive Mechanisms Impede Intratumoral Lymphocyte Infiltration into Colorectal Cancer Liver versus Lung MetastasesCancer Research Communications · 2023
- DNA2 Nuclease Inhibition Confers Synthetic Lethality in Cancers with Mutant p53 and Synergizes with PARP InhibitorsCancer Research Communications · 2023
- Chromatin Accessibility Landscape of Human Triple-negative Breast Cancer Cell Lines Reveals Variation by Patient Donor AncestryCancer Research Communications · 2023
- Piperacetazine Directly Binds to the PAX3::FOXO1 Fusion Protein and Inhibits Its Transcriptional ActivityCancer Research Communications · 2023
- The Inherited KRAS -variant as a Biomarker of Cetuximab Response in NSCLCCancer Research Communications · 2023
- Metastatic Competency and Tumor Spheroid Formation Are Independent Cell States Governed by RB in Lung AdenocarcinomaCancer Research Communications · 2023
- Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot ProjectCancer Research Communications · 2023
- An Early Neoplasia Index (ENI10), Based on Molecular Identity of CD10 Cells and Associated Stemness Biomarkers, is a Predictor of Patient Outcome in Many CancersCancer Research Communications · 2023
- Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency EvaluationCancer Research Communications · 2023
- Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate CancerCancer Research Communications · 2023
- Fusobacterium nucleatum Load Correlates with KRAS Mutation and Sessile Serrated Pathogenesis in Colorectal AdenocarcinomaCancer Research Communications · 2023
- Change in Neighborhood Socioeconomic Status and Adherence to the Cancer Prevention Lifestyle Guidelines in Hispanic/Latino Adults: Results from the HCHS/SOL StudyCancer Research Communications · 2023
- Effects and Eradication of Mycoplasma Contamination on Patient-derived Colorectal Cancer Organoid CulturesCancer Research Communications · 2023
- HER2-Selective and Reversible Tyrosine Kinase Inhibitor Tucatinib Potentiates the Activity of T-DM1 in Preclinical Models of HER2-positive Breast CancerCancer Research Communications · 2023
- Treatment Beyond Progression After Anti-PD-1 Blockade in Hepatocellular CarcinomaCancer Research Communications · 2023